Figure 1: Time- and dose-dependent action of Halowax 1051 on CYP1 A1 activity showed as a percentage of control. Cocultures of granulose and theca cells were exposed to 1, 10, and 100 pg/mL and 1 or 10 ng/mL of Halowax 1051. Each treatment was repeated three times ( ). Statistically significant differences between points in graph are indicated with different letters; the same letters indicating no significant differences, with a < b < c < d < e < f < g.